Technology Tempus Launches AI Assistant ‘Tempus One’ for Enhanced Research in Lens Data Analytics… Business Wire Feb 3, 2024 Tempus, a leader in artificial intelligence and precision medicine, announced the integration of its signature Tempus One technology into its Lens…
Technology Tempus is an In-Network Provider for Humana, Expanding Access to its Next-Gen Sequencing Tests Business Wire Jan 25, 2024 Tempus, a leader in artificial intelligence and precision medicine, announced that the company has signed agreements for in-network provider status…
Technology Tempus Introduces xM to Assess MRD in Patients with CRC for Research Use Only Business Wire Jan 22, 2024 Data on xM presented at the 2024 ASCO Gastrointestinal Cancers Symposium Tempus, a leader in artificial intelligence and precision medicine,…
Machine Learning Tempus Announces New ctDNA Assay, xF Monitor Business Wire Nov 6, 2023 Tumor uninformed treatment response monitoring assay for research use only Tempus, a leader in artificial intelligence and precision medicine,…
Machine Learning Tempus Announces the GEMINI Non-Small Cell Lung Cancer Study Business Wire Jul 12, 2023 Study aims to create the most robust, multi-omic dataset for patients with NSCLC Tempus, a leader in artificial intelligence and precision…
Machine Learning Tempus Announces Companion Diagnostic Collaboration with TScan Therapeutics Business Wire Jul 10, 2023 Tempus, a leader in artificial intelligence and precision medicine announced a new collaboration to develop a companion diagnostic (CDx) test with…
Machine Learning Tempus Announces Broad Launch of Tempus One Business Wire Jun 2, 2023 AI-enabled clinical assistant provides access to patient insights directly at your fingertips Tempus, a leader in artificial intelligence (AI) and…
Machine Learning Tempus Receives U.S. FDA Approval for xT CDx, a NGS-Based In Vitro Diagnostic Device Business Wire May 2, 2023 xT CDx is the company’s first Premarket Approval from the FDA Tempus, a leader in artificial intelligence and precision medicine, announced that…
Machine Learning Tempus Announces New Strategic Collaboration with Pfizer to Advance Oncology Therapeutic Development Business Wire Mar 1, 2023 Tempus, a leader in artificial intelligence (AI) and precision medicine, announced a multi-year, strategic collaboration with Pfizer in which the two…
Machine Learning Tempus Announces Prospective Study for Biomarker Discovery in Small Cell Lung Cancer AIT News Desk Jan 5, 2023 Tempus, a leader in artificial intelligence and precision medicine, announced a prospective study , in collaboration with AstraZeneca , that aims to…